2024-11-012026-03-312026-03-31false15198720MOSSLEY HEALTHCARE LIMITED2026-07-31falseiso4217:GBPxbrli:pure151987202024-10-31151987202026-03-31151987202024-11-012026-03-31151987202023-10-08151987202024-10-31151987202023-10-092024-10-3115198720bus:SmallEntities2024-11-012026-03-3115198720bus:AuditExempt-NoAccountantsReport2024-11-012026-03-3115198720bus:AbridgedAccounts2024-11-012026-03-3115198720bus:PrivateLimitedCompanyLtd2024-11-012026-03-3115198720core:WithinOneYear2026-03-3115198720core:AfterOneYear2026-03-3115198720core:WithinOneYear2024-10-3115198720core:AfterOneYear2024-10-3115198720core:ShareCapital2026-03-3115198720core:SharePremium2026-03-3115198720core:RevaluationReserve2026-03-3115198720core:OtherReservesSubtotal2026-03-3115198720core:RetainedEarningsAccumulatedLosses2026-03-3115198720core:ShareCapital2024-10-3115198720core:SharePremium2024-10-3115198720core:RevaluationReserve2024-10-3115198720core:OtherReservesSubtotal2024-10-3115198720core:RetainedEarningsAccumulatedLosses2024-10-3115198720core:LandBuildings2026-03-3115198720core:PlantMachinery2026-03-3115198720core:Vehicles2026-03-3115198720core:FurnitureFittings2026-03-3115198720core:OfficeEquipment2026-03-3115198720core:NetGoodwill2026-03-3115198720core:IntangibleAssetsOtherThanGoodwill2026-03-3115198720core:ListedExchangeTraded2026-03-3115198720core:UnlistedNon-exchangeTraded2026-03-3115198720core:LandBuildings2024-10-3115198720core:PlantMachinery2024-10-3115198720core:Vehicles2024-10-3115198720core:FurnitureFittings2024-10-3115198720core:OfficeEquipment2024-10-3115198720core:NetGoodwill2024-10-3115198720core:IntangibleAssetsOtherThanGoodwill2024-10-3115198720core:ListedExchangeTraded2024-10-3115198720core:UnlistedNon-exchangeTraded2024-10-3115198720core:LandBuildings2024-11-012026-03-3115198720core:PlantMachinery2024-11-012026-03-3115198720core:Vehicles2024-11-012026-03-3115198720core:FurnitureFittings2024-11-012026-03-3115198720core:OfficeEquipment2024-11-012026-03-3115198720core:NetGoodwill2024-11-012026-03-3115198720core:IntangibleAssetsOtherThanGoodwill2024-11-012026-03-3115198720core:ListedExchangeTraded2024-11-012026-03-3115198720core:UnlistedNon-exchangeTraded2024-11-012026-03-3115198720core:MoreThanFiveYears2024-11-012026-03-3115198720core:Non-currentFinancialInstruments2026-03-3115198720core:Non-currentFinancialInstruments2024-10-3115198720dpl:CostSales2024-11-012026-03-3115198720dpl:DistributionCosts2024-11-012026-03-3115198720core:LandBuildings2024-11-012026-03-3115198720core:PlantMachinery2024-11-012026-03-3115198720core:Vehicles2024-11-012026-03-3115198720core:FurnitureFittings2024-11-012026-03-3115198720core:OfficeEquipment2024-11-012026-03-3115198720dpl:AdministrativeExpenses2024-11-012026-03-3115198720core:NetGoodwill2024-11-012026-03-3115198720core:IntangibleAssetsOtherThanGoodwill2024-11-012026-03-3115198720dpl:GroupUndertakings2024-11-012026-03-3115198720dpl:ParticipatingInterests2024-11-012026-03-3115198720dpl:GroupUndertakingscore:ListedExchangeTraded2024-11-012026-03-3115198720core:ListedExchangeTraded2024-11-012026-03-3115198720dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-11-012026-03-3115198720core:UnlistedNon-exchangeTraded2024-11-012026-03-3115198720dpl:CostSales2023-10-092024-10-3115198720dpl:DistributionCosts2023-10-092024-10-3115198720core:LandBuildings2023-10-092024-10-3115198720core:PlantMachinery2023-10-092024-10-3115198720core:Vehicles2023-10-092024-10-3115198720core:FurnitureFittings2023-10-092024-10-3115198720core:OfficeEquipment2023-10-092024-10-3115198720dpl:AdministrativeExpenses2023-10-092024-10-3115198720core:NetGoodwill2023-10-092024-10-3115198720core:IntangibleAssetsOtherThanGoodwill2023-10-092024-10-3115198720dpl:GroupUndertakings2023-10-092024-10-3115198720dpl:ParticipatingInterests2023-10-092024-10-3115198720dpl:GroupUndertakingscore:ListedExchangeTraded2023-10-092024-10-3115198720core:ListedExchangeTraded2023-10-092024-10-3115198720dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-10-092024-10-3115198720core:UnlistedNon-exchangeTraded2023-10-092024-10-3115198720core:NetGoodwill2026-03-3115198720core:IntangibleAssetsOtherThanGoodwill2026-03-3115198720core:LandBuildings2026-03-3115198720core:PlantMachinery2026-03-3115198720core:Vehicles2026-03-3115198720core:FurnitureFittings2026-03-3115198720core:OfficeEquipment2026-03-3115198720core:AfterOneYear2026-03-3115198720core:WithinOneYear2026-03-3115198720core:ListedExchangeTraded2026-03-3115198720core:UnlistedNon-exchangeTraded2026-03-3115198720core:ShareCapital2026-03-3115198720core:SharePremium2026-03-3115198720core:RevaluationReserve2026-03-3115198720core:OtherReservesSubtotal2026-03-3115198720core:RetainedEarningsAccumulatedLosses2026-03-3115198720core:NetGoodwill2024-10-3115198720core:IntangibleAssetsOtherThanGoodwill2024-10-3115198720core:LandBuildings2024-10-3115198720core:PlantMachinery2024-10-3115198720core:Vehicles2024-10-3115198720core:FurnitureFittings2024-10-3115198720core:OfficeEquipment2024-10-3115198720core:AfterOneYear2024-10-3115198720core:WithinOneYear2024-10-3115198720core:ListedExchangeTraded2024-10-3115198720core:UnlistedNon-exchangeTraded2024-10-3115198720core:ShareCapital2024-10-3115198720core:SharePremium2024-10-3115198720core:RevaluationReserve2024-10-3115198720core:OtherReservesSubtotal2024-10-3115198720core:RetainedEarningsAccumulatedLosses2024-10-3115198720core:NetGoodwill2023-10-0815198720core:IntangibleAssetsOtherThanGoodwill2023-10-0815198720core:LandBuildings2023-10-0815198720core:PlantMachinery2023-10-0815198720core:Vehicles2023-10-0815198720core:FurnitureFittings2023-10-0815198720core:OfficeEquipment2023-10-0815198720core:AfterOneYear2023-10-0815198720core:WithinOneYear2023-10-0815198720core:ListedExchangeTraded2023-10-0815198720core:UnlistedNon-exchangeTraded2023-10-0815198720core:ShareCapital2023-10-0815198720core:SharePremium2023-10-0815198720core:RevaluationReserve2023-10-0815198720core:OtherReservesSubtotal2023-10-0815198720core:RetainedEarningsAccumulatedLosses2023-10-0815198720core:AfterOneYear2024-11-012026-03-3115198720core:WithinOneYear2024-11-012026-03-3115198720core:Non-currentFinancialInstrumentscore:CostValuation2024-11-012026-03-3115198720core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-11-012026-03-3115198720core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-11-012026-03-3115198720core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-11-012026-03-3115198720core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-11-012026-03-3115198720core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-11-012026-03-3115198720core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-11-012026-03-3115198720core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-11-012026-03-3115198720core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-11-012026-03-3115198720core:Non-currentFinancialInstrumentscore:CostValuation2026-03-3115198720core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-03-3115198720core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-03-3115198720core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-03-3115198720core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-03-3115198720core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-03-3115198720core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-03-3115198720core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-03-3115198720core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-03-3115198720core:Non-currentFinancialInstrumentscore:CostValuation2024-10-3115198720core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-10-3115198720core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-10-3115198720core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-10-3115198720core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-10-3115198720core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-10-3115198720core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-10-3115198720core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-10-3115198720core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-10-3115198720bus:Director12024-11-012026-03-31

MOSSLEY HEALTHCARE LIMITED

Registered Number
15198720
(England and Wales)

Unaudited Financial Statements for the Period ended
31 March 2026

MOSSLEY HEALTHCARE LIMITED
Company Information
for the period from 1 November 2024 to 31 March 2026

Director

AHMED, Azhar Ali

Registered Address

17 Titchfield Road
Oldham
OL8 2DW

Registered Number

15198720 (England and Wales)
MOSSLEY HEALTHCARE LIMITED
Balance Sheet as at
31 March 2026

Notes

31 Mar 2026

31 Oct 2024

£

£

£

£

Fixed assets
Intangible assets3321,196377,863
Tangible assets441,68241,776
362,878419,639
Current assets
Stocks560,12680,000
Debtors6327,456156,768
Cash at bank and on hand33,430118,354
421,012355,122
Creditors amounts falling due within one year7(678,020)(717,980)
Net current assets (liabilities)(257,008)(362,858)
Total assets less current liabilities105,87056,781
Creditors amounts falling due after one year8(1,000)(1,000)
Provisions for liabilities9(42,085)(41,213)
Net assets62,78514,568
Capital and reserves
Called up share capital100100
Profit and loss account62,68514,468
Shareholders' funds62,78514,568
The financial statements were approved and authorised for issue by the Director on 31 July 2026, and are signed on its behalf by:
AHMED, Azhar Ali
Director
Registered Company No. 15198720
MOSSLEY HEALTHCARE LIMITED
Notes to the Financial Statements
for the period ended 31 March 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard). These financial statements have been prepared for the seventeen-month period ended 31 March 2026. Comparative figures are for the twelve-month period ended 31 October 2024 and are therefore not directly comparable.
Going concern
At 31 March 2026, the company had net current liabilities of £257,008. Included within creditors falling due within one year is £534,288 owed to the company’s director and a person with significant control. The director and the person with significant control have confirmed their intention to continue providing financial support to the company and will not seek repayment of these amounts where doing so would prejudice the company’s ability to meet its liabilities as they fall due. Having considered the company’s current trading performance, cash-flow forecasts and the continued availability of related-party funding, the director has a reasonable expectation that the company has adequate resources to continue operating for at least 12 months from the date the financial statements are approved. The financial statements have therefore been prepared on the going-concern basis.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transaction can be measured reliably.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Intangible assets
Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in 'administrative expenses' in the profit and loss account. Goodwill is amortised on a straight-line basis over 10 years, being its estimated useful economic life.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)Straight line (years)
Plant and machinery20-
Fixtures and fittings-15
Office Equipment20-
Stocks and work in progress
Stock is valued at the lower of cost and estimated selling price less costs to complete and sell. The cost methodology employed by the entity is the first-in first-out method. Estimated selling price less costs to complete and sell are derived from the selling price which the goods would fetch in an open market transaction with established customers less the costs expected to be incurred to enable the sale to complete. Provision is made for slow-moving and obsolete items of stock. Such provisions are recognised in profit or loss. Work in progress is valued using the percentage of completion method and values are calculated using the lower of cost and estimated selling price less costs to complete and sell. When stocks are sold, the carrying amount of those stocks is recognised as an expense within cost of sales. This takes place in the same period that the associated revenue is recognised.
2.Average number of employees

20262024
Average number of employees during the year66
3.Intangible assets

Total

£
Cost or valuation
At 01 November 24400,000
At 31 March 26400,000
Amortisation and impairment
At 01 November 2422,137
Charge for year56,667
At 31 March 2678,804
Net book value
At 31 March 26321,196
At 31 October 24377,863
4.Tangible fixed assets

Total

£
Cost or valuation
At 01 November 2443,689
Additions5,593
At 31 March 2649,282
Depreciation and impairment
At 01 November 241,913
Charge for year5,687
At 31 March 267,600
Net book value
At 31 March 2641,682
At 31 October 2441,776
5.Stocks

2026

2024

££
Raw materials and consumables60,12680,000
Total60,12680,000
6.Debtors: amounts due within one year

2026

2024

££
Trade debtors / trade receivables110,46416,396
Other debtors207,77858,478
Prepayments and accrued income9,21481,894
Total327,456156,768
7.Creditors: amounts due within one year

2026

2024

££
Trade creditors / trade payables108,817205,875
Taxation and social security33,59512,555
Other creditors534,288499,550
Accrued liabilities and deferred income1,320-
Total678,020717,980
8.Creditors: amounts due after one year

2026

2024

££
Other creditors1,0001,000
Total1,0001,000
9.Provisions for liabilities
The provision relates to the estimated cost of restoring the company’s leased property at the end of the lease term. The amount represents management’s best estimate of the expenditure required to settle the obligation. At 1 November 2024: £40,500 Amounts provided/utilised during the period: £nil At 31 March 2026: £40,500

2026

2024

££
Net deferred tax liability (asset)1,585713
Other provisions40,50040,500
Total42,08541,213
10.Related party transactions
At 31 March 2026, the company owed £221,660 to its director, Azhar Ali Ahmed, and £312,629 to Ansar Mahmood, a person with significant control. The total amount owed to related parties was £534,288 (2024: £499,551). The loans are unsecured, interest-free and repayable on demand. The amounts are included within creditors falling due within one year.
11.Change in reporting period and impact on comparability
These financial statements have been prepared for the seventeen-month period ended 31 March 2026. Comparative figures are for the twelve-month period ended 31 October 2024 and are therefore not directly comparable.